Compare TARS & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARS | NATL |
|---|---|---|
| Founded | 2016 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2020 | 2023 |
| Metric | TARS | NATL |
|---|---|---|
| Price | $64.46 | $42.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $89.00 | $45.60 |
| AVG Volume (30 Days) | 526.9K | ★ 1.4M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.21 | ★ 73.98 |
| EPS | N/A | ★ 2.14 |
| Revenue | $451,360,000.00 | ★ $4,354,000,000.00 |
| Revenue This Year | $55.67 | $6.13 |
| Revenue Next Year | $30.64 | $4.24 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | ★ 146.71 | 0.86 |
| 52 Week Low | $38.51 | $22.30 |
| 52 Week High | $85.25 | $48.50 |
| Indicator | TARS | NATL |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 45.30 |
| Support Level | $61.11 | $37.97 |
| Resistance Level | $67.70 | $43.43 |
| Average True Range (ATR) | 2.32 | 1.10 |
| MACD | -0.89 | -0.52 |
| Stochastic Oscillator | 3.08 | 3.79 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.